DCGI extends shelf life of Covishield from 6 to 9 months
India’s drug regulator DCGI has extended the period of Covishield, the Oxford-AstraZeneca COVID-19 immunogen, from 6 to 9 months from its producing date.
In a letter to the bodily fluid Institute of Republic of India, medication Controller General of Republic of India V G Somani same the SII is allowable to use the period of 9 months to untagged vials out there existing time period is that the length of time that associate item remains fit use.
The DCGI same it’s no objection in respect of ‘Extension of period of Covishield Vaccine’ in multi-dose glass bottle (10 dose-5ml) from six months to 9 months.
“You are allowable to use the period of 9 months to untagged vials out there existing, subject to the condition that the main points of such stock, batch-wise, shall be submitted to the current workplace and Central medication Laboratory, Kasauli,” Somani same within the letter.